Communicating statin evidence to support shared decision-making

被引:13
|
作者
Barrett, Bruce [1 ]
Ricco, Jason [2 ]
Wallace, Margaret [3 ]
Kiefer, David [4 ]
Rakel, Dave [5 ]
机构
[1] Univ Wisconsin, Dept Family Med & Community Hlth, 1100 Delaplaine Court, Madison, WI 53715 USA
[2] Univ Minnesota, Dept Family Med & Community Hlth, Minneapolis, MN 55455 USA
[3] HealthEast Care Syst, St Paul, MN 55102 USA
[4] Grp Hlth Cooperat, Madison, WI 53703 USA
[5] Univ Wisconsin, Dept Family Med & Community Hlth, Madison, WI 53715 USA
关键词
Attitude to health; Cholesterol; Clinical significance; Cost-benefit analysis; Decision making; Evidence-based medicine; Guidelines; Lipids; Minimal important difference; Outcomes; Patient preference; Preventive cardiology; Primary care; Quality of life; Shared decision-making; Statins; SUFFICIENTLY IMPORTANT DIFFERENCE; PATIENT-ORIENTED EVIDENCE; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; PATIENTS EXPERIENCES; DIABETES-MELLITUS; LDL CHOLESTEROL; LOW-RISK; METAANALYSIS; GUIDELINES;
D O I
10.1186/s12875-016-0436-9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The practice of clinical medicine rests on a foundation of ethical principles as well as scientific knowledge. Clinicians must artfully balance the principle of beneficence, doing what is best for patients, with autonomy, allowing patients to make their own well-informed health care decisions. The clinical communication process is complicated by varying degrees of confidence in scientific evidence regarding patient-oriented benefits, and by the fact that most medical options are associated with possible harms as well as potential benefits. Discussion: Evidence-based clinical guidelines often neglect patient-oriented issues involved with the thoughtful practice of shared decision-making, where individual values, goals, and preferences should be prioritized. Guidelines on the use of statin medications for preventing cardiovascular events are a case in point. Current guidelines endorse the use of statins for people whose 10-year risk of cardiovascular events is as low as 7.5 %. Previous guidelines set the 10-year risk benchmark at 20 %. Meta-analysis of randomized trials suggests that statins can reduce cardiovascular event rates by about 25 %, bringing 10-year risk from 7.5 to 5.6 %, for example, or from 20 to 15 %. Whether or not these benefits should justify the use of statins for individual patients depends on how those advantages are valued in comparison with disadvantages, such as side effect risks, and with inconveniences associated with taking a pill each day and visiting clinicians and laboratories regularly. Conclusions: Whether or not the overall benefit-harm balance justifies the use of a medication for an individual patient cannot be determined by a guidelines committee, a health care system, or even the attending physician. Instead, it is the individual patient who has a fundamental right to decide whether or not taking a drug is worthwhile. Researchers and professional organizations should endeavor to develop shared decision-making tools that provide up-to-date best evidence in easily understandable formats, so as to assist clinicians in helping their patients to make the decisions that are right for them.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Communicating statin evidence to support shared decision-making
    Bruce Barrett
    Jason Ricco
    Margaret Wallace
    David Kiefer
    Dave Rakel
    [J]. BMC Family Practice, 17
  • [2] Communicating shared decision-making: Cancer patient perspectives
    Thorne, Sally
    Oliffe, John L.
    Stajduhar, Kelli I.
    [J]. PATIENT EDUCATION AND COUNSELING, 2013, 90 (03) : 291 - 296
  • [3] Shared decision-making and decision support: their role in obstetrics and gynecology
    Edmonds, Brownsyne Tucker
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (06) : 523 - 530
  • [4] Shared Decision-Making Is Not Patient Decision-Making
    Birnbrich, Alysa
    McCulloch, Patrick C.
    Kraeutler, Matthew J.
    [J]. SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2023, 15 (04): : 615 - 616
  • [5] A shared decision-making intervention by pharmacy students to improve statin adherence
    Osbaugh, Nicole A.
    Billups, Sarah J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2022, 5 (01): : 34 - 41
  • [6] Shared decision-making
    Dirksen-Fischer, M
    [J]. GESUNDHEITSWESEN, 2004, 66 (05) : 318 - 318
  • [7] Shared decision-making
    Steven, K
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2001, 51 (462): : 61 - 62
  • [8] Shared Decision-Making
    Wright, Linda S.
    [J]. NEPHROLOGY NURSING JOURNAL, 2022, 49 (06) : 537 - 540
  • [9] Shared decision-making
    Berger, Abi
    [J]. BMJ SEXUAL & REPRODUCTIVE HEALTH, 2019, 45 (02) : 168 - 168
  • [10] Shared decision-making and evidence-based practice
    Adams, JR
    Drake, RE
    [J]. COMMUNITY MENTAL HEALTH JOURNAL, 2006, 42 (01) : 87 - 105